No further details on this right now.

US$50bn is a substantial investment from the firm.

AstraZeneca plc is a British-Swedish pharmaceutical and biotechnology firm

  • headquarters in Cambridge, UK
AstraZeneca

Visit investingLive.com (formerly ForexLive.com) for additional, original views.

Source: Forex Live